Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: J Biol Inorg Chem. 2011 Sep 15;17(1):123–132. doi: 10.1007/s00775-011-0836-1

Fig. 3.

Fig. 3

c-DDP, oxaliplatin, and BBR3464 binding (with standard deviations) to human serum albumin (HSA) in the presence and absence of desipramine. The platinum drugs and desipramine are in a 1:1 molar ratio. The drugs and HSA are in a 1:3 molar ratio. The BBR3464 concentration is divided by 3 to reflect the trinuclear nature of the drug